Question · Q1 2024
Tristan Lamar of Deutsche Bank asked for clarification on Solvay's remaining exposure to PFAS after the demerger, any outstanding provisions, and which specific businesses were involved.
Answer
CEO Philippe Kehren confirmed that remaining exposure is limited to the Trifluoroacetic acid (TFA) business, produced at a single site in France. He emphasized that TFA is a small, non-polymeric molecule that does not accumulate in the body like PFAS of concern. He affirmed the company is fully compliant and continues to invest in emission reduction for what he described as a small but essential business.
Ask follow-up questions
Fintool can predict
SLVYY's earnings beat/miss a week before the call